Emi Ono, Mari Tohya, Tatsuya Tada, Tomomi Hishinuma, Shin Watanabe, Kyoko Kuwahara-Arai, Teruo Kirikae
{"title":"Emergence of carbapenem-resistant <i>Pseudomonas alcaligenes</i> and <i>Pseudomonas paralcaligenes</i> clinical isolates with plasmids harbouring <i>bla</i> <sub>IMP-1</sub> in Japan.","authors":"Emi Ono, Mari Tohya, Tatsuya Tada, Tomomi Hishinuma, Shin Watanabe, Kyoko Kuwahara-Arai, Teruo Kirikae","doi":"10.1099/jmm.0.001684","DOIUrl":null,"url":null,"abstract":"<p><p><b>Introduction.</b> The emergence of carbapenem-resistant <i>Pseudomonas</i> species producing metallo-β-lactamase (MBL) has become a serious medical problem worldwide. IMP-type MBL was firstly detected in 1991 in Japan. Since then, it has become one of the most prevalent types of MBLs.<b>Hypothesis/Gap statement.</b> Avirulent species of <i>Pseudomonas</i>, such as <i>Pseudomonas alcaligenes</i>, function as reservoirs of drug resistance-associated genes encoding carbapenemases in clinical settings.<b>Methodology.</b> Active surveillance for carbapenem-resistant Gram-negative pathogens was conducted in 2019 at a hospital in Tokyo, Japan. Of the 543 samples screened for carbapenem-resistant isolates, 2 were species of <i>Pseudomonas</i>. One was from a stool sample from a medical staff member, and the other was from a stool sample from a hospitalized patient.<b>Results.</b> Whole-genome sequencing showed that the former isolate was a strain of <i>P. alcaligenes</i>, and the latter was a strain of <i>Pseudomonas paralcaligenes</i>, a species close to <i>P. alcaligenes</i>. Both isolates were resistant to all carbapenems and harboured <i>bla</i> <sub>IMP-1</sub> genes encoding IMP-1 MBL, which conferred resistance to carbapenems. The <i>bla</i> <sub>IMP-1</sub> genes of <i>P. alcaligenes</i> and <i>P. paralcaligenes</i> were located on the plasmids, pMRCP2, 323125 bp in size, and pMRCP1333, 16592 bp in size, respectively. The sequence of 82 % of pMRCP2 was 92 % similar to the sequence of a plasmid of <i>P. aeruginosa</i> PA83, whereas the sequence of 79 % of pMRCP1333 was >95 % similar to the sequence of a plasmid of <i>Achromobacter xylosoxidans</i> FDAARGOS 162. The genomic environments surrounding the <i>bla</i> <sub>IMP-1</sub> of pMRCP2 and pMRCP1333 differed completely from each other.<b>Conclusions.</b> These results indicate that the two isolates acquired <i>bla</i> <sub>IMP-1</sub> from different sources and that <i>P. alcaligenes</i> and <i>P. paralcaligenes</i> function as vectors and reservoirs of carbapenem-resistant genes in hospitals.</p>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":"72 3","pages":""},"PeriodicalIF":4.6000,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1099/jmm.0.001684","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction. The emergence of carbapenem-resistant Pseudomonas species producing metallo-β-lactamase (MBL) has become a serious medical problem worldwide. IMP-type MBL was firstly detected in 1991 in Japan. Since then, it has become one of the most prevalent types of MBLs.Hypothesis/Gap statement. Avirulent species of Pseudomonas, such as Pseudomonas alcaligenes, function as reservoirs of drug resistance-associated genes encoding carbapenemases in clinical settings.Methodology. Active surveillance for carbapenem-resistant Gram-negative pathogens was conducted in 2019 at a hospital in Tokyo, Japan. Of the 543 samples screened for carbapenem-resistant isolates, 2 were species of Pseudomonas. One was from a stool sample from a medical staff member, and the other was from a stool sample from a hospitalized patient.Results. Whole-genome sequencing showed that the former isolate was a strain of P. alcaligenes, and the latter was a strain of Pseudomonas paralcaligenes, a species close to P. alcaligenes. Both isolates were resistant to all carbapenems and harboured blaIMP-1 genes encoding IMP-1 MBL, which conferred resistance to carbapenems. The blaIMP-1 genes of P. alcaligenes and P. paralcaligenes were located on the plasmids, pMRCP2, 323125 bp in size, and pMRCP1333, 16592 bp in size, respectively. The sequence of 82 % of pMRCP2 was 92 % similar to the sequence of a plasmid of P. aeruginosa PA83, whereas the sequence of 79 % of pMRCP1333 was >95 % similar to the sequence of a plasmid of Achromobacter xylosoxidans FDAARGOS 162. The genomic environments surrounding the blaIMP-1 of pMRCP2 and pMRCP1333 differed completely from each other.Conclusions. These results indicate that the two isolates acquired blaIMP-1 from different sources and that P. alcaligenes and P. paralcaligenes function as vectors and reservoirs of carbapenem-resistant genes in hospitals.